02233nas a2200169   4500000000100000008004100001100001400042700001800056700001400074700001400088245013200102250001500234300001200249490000600261520176900267020002702036       2015                            d1 aHuxley R.1 aWoodward Mark1 aPeters S.1 aMishra G.00aRisk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis  a2015/02/11  a198-2060 v33 a<p>
BACKGROUND: Studies have suggested sex differences in the mortality rate associated with type 1 diabetes. We did a meta-analysis to provide reliable estimates of any sex differences in the effect of type 1 diabetes on risk of all-cause mortality and cause-specific outcomes. METHODS: We systematically searched PubMed for studies published between Jan 1, 1966, and Nov 26, 2014. Selected studies reported sex-specific estimates of the standardised mortality ratio (SMR) or hazard ratios associated with type 1 diabetes, either for all-cause mortality or cause-specific outcomes. We used random effects meta-analyses with inverse variance weighting to obtain sex-specific SMRs and their pooled ratio (women to men) for all-cause mortality, for mortality from cardiovascular disease, renal disease, cancer, the combined outcome of accident and suicide, and from incident coronary heart disease and stroke associated with type 1 diabetes. FINDINGS: Data from 26 studies including 214 114 individuals and 15 273 events were included. The pooled women-to-men ratio of the SMR for all-cause mortality was 1.37 (95% CI 1.21-1.56), for incident stroke 1.37 (1.03-1.81), for fatal renal disease 1.44 (1.02-2.05), and for fatal cardiovascular diseases 1.86 (1.62-2.15). For incident coronary heart disease the sex difference was more extreme; the pooled women-to-men ratio of the SMR was 2.54 (95% CI 1.80-3.60). No evidence suggested a sex difference for mortality associated with type 1 diabetes from cancer, or accident and suicide. INTERPRETATION: Women with type 1 diabetes have a roughly 40% greater excess risk of all-cause mortality, and twice the excess risk of fatal and nonfatal vascular events, compared with men with type 1 diabetes. FUNDING: None.
</p>
  a2213-8595 (Electronic)